损伤部位与严重程度对创伤后阿片类药物使用的影响
本研究利用Optum Clinformatics数据库,纳入2010年1月至2017年6月因创伤入院、出院后无阿片类用药史的患者26,437例,定义新发持续阿片类药物使用(NPOU)为出院后0-14天两次不同处方且出院后91-180天至少1次续药,或出院后15-90天配药且91-180天再次配药。结果显示2,277例(8.6%)符合NPOU标准。多因素回归校正后,四肢损伤(aOR 1.75, 95%CI 1.57-1.94)和腹部损伤(aOR 1.42, 95%CI 1.22-1.64)与NPOU显著相关;任一身体区域最大简明损伤定级(MAIS)≥2者较MAIS=1者NPOU风险增加1.49倍(95%CI 1.28-1.73);基于损伤严重度评分(ISS)的总损伤负担分组间未见差异。结论提示四肢和腹部损伤患者为高危人群,最大单一区域损伤严重度预测NPOU,而总损伤严重度不预测。
要点
- 创伤后出院患者中8.6%(2,277/26,437)符合新发持续阿片类药物使用(NPOU)标准。
- 四肢损伤患者NPOU风险显著升高(aOR 1.75, 95%CI 1.57-1.94),腹部损伤亦升高(aOR 1.42, 95%CI 1.22-1.64)。
- 任一身体区域MAIS≥2者较MAIS=1者NPOU风险增加1.49倍(95%CI 1.28-1.73)。
- 基于ISS的总损伤负担分组间NPOU无差异,提示总损伤严重度不预测持续使用。
- 出院后阿片类药物续药模式(0-14天两次处方+91-180天续药,或15-90天配药+91-180天续药)用于定义NPOU。
适用人群与场景
- 2010年1月至2017年6月因创伤入院、出院后无阿片类用药史(opioid-naive)的患者,数据来自Optum Clinformatics数据库。
- 原文未提及排除人群、急诊/ICU/院前场景及病情阶段的具体限定。
诊断标准与关键阈值
- 新发持续阿片类药物使用(NPOU)定义:满足以下任一场景:(1)出院后0-14天两次不同阿片类处方配药,且出院后91-180天至少1次配药;或(2)出院后15-90天配药,且出院后91-180天配药。
- 损伤严重度评估:最大简明损伤定级(MAIS)按身体区域评分,MAIS≥2与MAIS=1比较;总损伤负担采用损伤严重度评分(ISS)分组。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性队列研究,使用Optum Clinformatics数据库,纳入26,437例创伤后无阿片类用药史患者。
- 主要终点:NPOU发生率8.6%(2,277例)。
- 四肢损伤与NPOU独立相关(aOR 1.75, 95%CI 1.57-1.94);腹部损伤亦相关(aOR 1.42, 95%CI 1.22-1.64)。
- 任一身体区域MAIS≥2者较MAIS=1者NPOU风险增加1.49倍(95%CI 1.28-1.73)。
- 基于ISS的总损伤负担分组间NPOU未见差异。
- 原文未提及关键次要终点及不良事件的具体数据。
证据类型、等级与局限
- 证据类型:回顾性队列研究(预后与流行病学),证据等级Level III。
- 局限:原文未明确列出局限;设计本身为回顾性数据库研究,可能存在未测量混杂。
对床旁实践的改变
- 对四肢或腹部损伤的创伤出院患者,应警惕新发持续阿片类药物使用风险,考虑更密切的随访和处方管理。
- 评估持续阿片使用风险时,最大单一区域损伤严重度(MAIS≥2)比总损伤严重度(ISS分组)更有预测价值。
- 原文未提及具体干预措施或改变实践的推荐,仅提示风险分层。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Recent data have suggested that persistent opioid use is prevalent following trauma. The effect of type of injury and total injury burden is not known. We sought to characterize the relationship between injury location and severity and risk of persistent opioid use.
METHODS: We investigated postdischarge opioid utilization among patients who were admitted for trauma between January 2010 and June 2017 using the Optum Clinformatics Database. New persistent opioid use (NPOU) was defined as one of the following scenarios: (1) two separate opioid prescription fills between 0 and 14 days postdischarge and having 1+ fills in the 91 to 180 days following discharge or (2) filling a prescription in the 15 to 90 days following discharge in addition to a filling in the 91 to 180 day postdischarge period. Multivariable logistic regression was used to assess the relationship between injury type and severity with new persistent opioid use development.
RESULTS: A total of 26,437 opioid-naive patients were included in the analysis. Overall, 2,277 patients (8.6%) met the criteria for NPOU. After adjustment for confounding, NPOU was significantly more common for patients with injury to the extremities (adjusted odds ratio [aOR], 1.75; 95% confidence interval [CI], 1.57-1.94) or abdomen (adjusted odds ratio [aOR], 1.42; 95% CI, 1.22-1.64). Importantly, patients with maximum Abbreviated Injury Scale score of ≥2 for any body region had 1.49-fold odds of NPOU compared with patients with score of 1 (95% CI, 1.28-1.73), while no difference was seen across groupings of total injury burden based on Injury Severity Score.
CONCLUSION: New persistent opioid use is common among patients suffering from trauma. In addition, patients suffering from extremity and abdominal injuries are at highest risk. Maximum individual region injury severity predicts development of new persistent use, whereas total injury severity does not.
LEVEL OF EVIDENCE: Prognostic and epidemiological, level III.
参考来源
- Baker RC, Brown CS, Montgomery JR, et al. Effect of injury location and severity on opioid use after trauma. J Trauma Acute Care Surg. 2021. PMID: 34144565. doi:10.1097/TA.0000000000003138
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。